AZN - AstraZeneca PLC

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
44,351,000
44,351,000
37,417,000
26,617,000
24,384,000
Cost of revenue
12,391,000
12,391,000
12,437,000
5,299,000
4,921,000
Gross profit
31,960,000
31,960,000
24,980,000
21,318,000
19,463,000
Operating expenses
Research development
9,762,000
9,762,000
9,736,000
5,991,000
5,958,000
Selling general and administrative
17,935,000
18,955,000
15,680,000
11,693,000
11,848,000
Total operating expenses
27,399,000
28,203,000
23,924,000
16,156,000
16,265,000
Operating income or loss
4,561,000
3,757,000
1,056,000
5,162,000
3,198,000
Interest expense
1,330,000
1,346,000
1,300,000
1,306,000
1,432,000
Income before tax
2,501,000
2,501,000
-265,000
3,916,000
1,548,000
Income tax expense
-792,000
-792,000
-380,000
772,000
321,000
Income from continuing operations
3,293,000
3,293,000
115,000
3,144,000
1,227,000
Net income
3,288,000
3,288,000
112,000
3,196,000
1,335,000
Net income available to common shareholders
3,288,000
3,288,000
112,000
3,196,000
1,335,000
Basic EPS
-
1.06
0.04
1.22
0.52
Diluted EPS
-
1.05
0.04
1.22
0.52
Basic average shares
-
3,096,000
2,836,000
2,624,000
2,602,000
Diluted average shares
-
3,120,000
2,854,000
2,626,000
2,602,000
EBITDA
-
9,327,000
7,565,000
8,371,000
6,742,000